4
Changes in Ownership
4D Molecular Therapeutics, Inc. Filed Acc 0000950170-24-014091
Chief Executive Officer sold 92,001 shares at $27.13 ($2,495,822)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Kirn David Chief Executive Officer | 2024-02-08 | Sale 10b5-1 | −92,001 | $27.13 | $2,495,822 | 1,059,153 | D |
| Open-market sales · 92,001 sh · avg $27.13 · $2,495,822 | |||||||
Loading xslF345X05/ownership.xml…